William Garrett Gray Checkpoint Therapeutics, Inc. (CKPT) insider trading activity

CKPT Quotes by TradingView

William Garrett Gray is Chief Financial Officer of Checkpoint Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CKPT, which is worth approximately $0. The most recent transaction as insider was on May 30, 2025, when has been sold 1,446,322 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

WILLIAM GARRETT GRAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
1,446,322 Reduced 100.0%
0 Common Stock
Apr 01 2025
SELL
Open market or private sale
$49,904 $4.05 p/Share
12,322 Reduced 0.84%
1,446,322 Common Stock
Feb 06 2025
SELL
Open market or private sale
$271,983 $3.67 p/Share
74,110 Reduced 4.84%
1,458,644 Common Stock
Jan 30 2025
BUY
Grant, award, or other acquisition
-
500,000 Added 24.6%
1,532,754 Common Stock (restricted)
Dec 18 2024
SELL
Open market or private sale
$1,076,412 $4.01 p/Share
268,432 Reduced 20.63%
1,032,754 Common Stock
Dec 13 2024
BUY
Grant, award, or other acquisition
-
629,000 Added 32.59%
1,301,186 Common Stock
Jun 26 2024
SELL
Open market or private sale
$26,858 $2.06 p/Share
13,038 Reduced 1.9%
672,186 Common Stock
May 24 2024
BUY
Grant, award, or other acquisition
-
540,000 Added 44.07%
685,224 Common Stock (restricted)
Feb 28 2024
SELL
Open market or private sale
$4,212 $2.07 p/Share
2,035 Reduced 1.38%
145,224 Common Stock
Feb 01 2024
SELL
Open market or private sale
$8,024 $1.95 p/Share
4,115 Reduced 2.72%
147,259 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 39.78%
151,374 Common Stock (restricted)
Mar 02 2023
SELL
Open market or private sale
$17,955 $5.0 p/Share
3,591 Reduced 6.53%
51,374 Common Stock
Feb 27 2023
SELL
Open market or private sale
$8,919 $4.66 p/Share
1,914 Reduced 3.88%
47,465 Common Stock
Feb 27 2023
BUY
Grant, award, or other acquisition
-
7,500 Added 12.01%
54,965 Common Stock
Feb 01 2023
SELL
Open market or private sale
$15,107 $4.79 p/Share
3,154 Reduced 6.0%
49,379 Common Stock
Jan 10 2023
SELL
Open market or private sale
$12,541 $6.75 p/Share
1,858 Reduced 3.42%
52,533 Common Stock
Mar 10 2022
SELL
Open market or private sale
$72,192 $1.89 p/Share
38,197 Reduced 6.56%
543,910 Common Stock
Feb 01 2022
SELL
Open market or private sale
$93,028 $2.51 p/Share
37,063 Reduced 5.99%
582,107 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
-
137,000 Added 18.12%
619,170 Common Stock (restricted)
Feb 04 2021
SELL
Open market or private sale
$96,331 $3.66 p/Share
26,320 Reduced 5.18%
482,170 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
151,000 Added 22.9%
508,490 Common Stock (restricted)
Dec 22 2020
SELL
Open market or private sale
$6,713 $2.79 p/Share
2,406 Reduced 0.67%
357,490 Common Stock
WGG

William Garrett Gray

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on CKPT

Follow Checkpoint Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CKPT shares.

Notify only if

Insider Trading

Get notified when an Checkpoint Therapeutics, Inc. insider buys or sells CKPT shares.

Notify only if

News

Receive news related to Checkpoint Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CKPT